🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, double-blind, controlled Phase 2/3 trial...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #2
Start Date
2024-06-07
Trial ID
NCT06082167
Treatments Being Tested
The investigators hypothesize that the combination of eribulin and zanzalin...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2025-10-22
Trial ID
NCT06957431
Treatments Being Tested
This phase II trial tests how well zanzalintinib (XL092) works in treating ...
Status
Recruiting
Location
Northwestern University
Start Date
2024-09-19
Trial ID
NCT06571734
The primary purpose of this study is to assess the effectiveness of zanzali...
Status
Recruiting
Location
The University of Alabama at Birmingham
Start Date
2025-07-21
Trial ID
NCT06943755
Treatments Being Tested
Researchers are looking for new ways to treat advanced renal cell carcinoma...
Status
Recruiting
Location
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0102)
Start Date
2026-04-09
Trial ID
NCT07489495
Treatments Being Tested
The purpose of this study is to determine the recommended Phase 2 dose of z...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2025-10-17
Trial ID
NCT06795009
Treatments Being Tested
The objective of the study is to evaluate efficacy and safety of zanzalinti...
Status
Recruiting
Location
University of Alabama
Start Date
2026-05-21
Trial ID
NCT07428616
Treatments Being Tested
This study will evaluate the efficacy, safety, and pharmacokinetics of immu...
Status
Terminated
Location
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley
Start Date
2017-12-27
Trial ID
NCT03337698
This Phase I clinical trial evaluates the safety, tolerability, and optimal...
Status
Recruiting
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2025-09-29
Trial ID
NCT06912087
Treatments Being Tested
To study the treatment efficacy of zanzalintinib monotherapy in patients wi...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2025-12-05
Trial ID
NCT07193550
Treatments Being Tested